218 related articles for article (PubMed ID: 18538271)
1. [Renal carcinoma associated with MiTF/TFE translocation: report of six cases in young adults].
Hintzy MC; Camparo P; Vasiliu V; Peyromaure M; Vieillefond A
Prog Urol; 2008 May; 18(5):275-80. PubMed ID: 18538271
[TBL] [Abstract][Full Text] [Related]
2. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
[TBL] [Abstract][Full Text] [Related]
3. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
[TBL] [Abstract][Full Text] [Related]
4. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.
Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY
Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148
[TBL] [Abstract][Full Text] [Related]
5. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
6. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient.
Haudebourg J; Hoch B; Fabas T; Burel-Vandenbos F; Carpentier X; Amiel J; Cardot-Leccia N; Michiels JF; Pedeutour F
Cancer Genet Cytogenet; 2010 Jul; 200(2):75-8. PubMed ID: 20620589
[TBL] [Abstract][Full Text] [Related]
7. Translocation carcinomas of the kidney.
Argani P; Ladanyi M
Clin Lab Med; 2005 Jun; 25(2):363-78. PubMed ID: 15848741
[TBL] [Abstract][Full Text] [Related]
8. Translocation carcinomas of the kidney after chemotherapy in childhood.
Argani P; Laé M; Ballard ET; Amin M; Manivel C; Hutchinson B; Reuter VE; Ladanyi M
J Clin Oncol; 2006 Apr; 24(10):1529-34. PubMed ID: 16575003
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman.
LaGrange CA; Lele SM; Strup SE
Urology; 2007 Sep; 70(3):590.e11-2. PubMed ID: 17905124
[TBL] [Abstract][Full Text] [Related]
10. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults.
Meyer PN; Clark JI; Flanigan RC; Picken MM
Am J Clin Pathol; 2007 Jul; 128(1):70-9. PubMed ID: 17580272
[TBL] [Abstract][Full Text] [Related]
11. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.
Pecciarini L; Cangi MG; Lo Cunsolo C; Macri' E; Dal Cin E; Martignoni G; Doglioni C
Genes Chromosomes Cancer; 2007 May; 46(5):419-26. PubMed ID: 17285572
[TBL] [Abstract][Full Text] [Related]
12. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.
Mir MC; Trilla E; de Torres IM; Panizo A; Zlotta AR; Van Rhijn B; Morote J
BJU Int; 2011 Jul; 108(2 Pt 2):E71-6. PubMed ID: 21070573
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.
Martignoni G; Pea M; Gobbo S; Brunelli M; Bonetti F; Segala D; Pan CC; Netto G; Doglioni C; Hes O; Argani P; Chilosi M
Mod Pathol; 2009 Aug; 22(8):1016-22. PubMed ID: 19396149
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.
Müller-Höcker J; Babaryka G; Schmid I; Jung A
Pathol Res Pract; 2008; 204(8):589-97. PubMed ID: 18358634
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.
Medendorp K; van Groningen JJ; Schepens M; Vreede L; Thijssen J; Schoenmakers EF; van den Hurk WH; Geurts van Kessel A; Kuiper RP
Cytogenet Genome Res; 2007; 118(2-4):157-65. PubMed ID: 18000366
[TBL] [Abstract][Full Text] [Related]
16. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
[TBL] [Abstract][Full Text] [Related]
17. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
19. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
[TBL] [Abstract][Full Text] [Related]
20. Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.
Heimann P; El Housni H; Ogur G; Weterman MA; Petty EM; Vassart G
Cancer Res; 2001 May; 61(10):4130-5. PubMed ID: 11358836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]